Skip to main navigation Skip to search Skip to main content

Determinants of Urogenital Schistosomiasis Among Pregnant Women and its Association With Pregnancy Outcomes, Neonatal Deaths, and Child Growth

  • Wellington Murenjekwa
  • , Rachel Makasi
  • , Robert Ntozini
  • , Bernard Chasekwa
  • , Kuda Mutasa
  • , Lawrence H. Moulton
  • , James M. Tielsch
  • , Jean H. Humphrey
  • , Laura E. Smith
  • , Andrew J. Prendergast
  • , Claire D. Bourke
  • Zvitambo Institute for Maternal and Child Health Research
  • Johns Hopkins University
  • George Washington University
  • Queen Mary University of London

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Background: Schistosoma haematobium is a parasitic helminth that causes urogenital pathology. The impact of urogenital schistosomiasis during pregnancy on birth outcomes and child growth is poorly understood. Methods: Risk factors for urogenital schistosomiasis were characterized among 4437 pregnant women enrolled in a cluster-randomized community-based trial in rural Zimbabwe. Infection was defined via urine microscopy (≥1 S. haematobium egg) and urinalysis (hematuria). Associations between infection and pregnancy outcomes were assessed in case-control analyses using conditional logistic regression. The association of maternal infection with birthweight and length-for-age Z scores (LAZ) at 1 and 18 months of age were assessed using generalized estimating equations. Results: Urogenital schistosomiasis (egg positive and/or hematuria positive) was detected in 26.8% of pregnant women. Risk factors significantly associated with infection were maternal age, education, marital status, and religion; household drinking water source and latrine; study region; and season. Urogenital schistosomiasis was not significantly associated with adverse pregnancy outcomes (miscarriage, stillbirth, preterm, and small-for-gestational age), birthweight, neonatal death, or LAZ. Conclusions: Including pregnant women in antihelminthic treatment programs would benefit a large number of women in rural Zimbabwe. However, clearance of the low-intensity infections that predominate in this context is unlikely to have additive benefits for pregnancy outcomes or child growth. Clinical Trials Registration: NCT01824940.

Original languageEnglish
Pages (from-to)1433-1444
Number of pages12
JournalJournal of Infectious Diseases
Volume223
Issue number8
DOIs
StatePublished - Apr 15 2021

Keywords

  • Schistosoma haematobium
  • Zimbabwe
  • adverse birth outcomes
  • birthweight
  • child health
  • pregnancy
  • schistosomiasis
  • stunting
  • women

Fingerprint

Dive into the research topics of 'Determinants of Urogenital Schistosomiasis Among Pregnant Women and its Association With Pregnancy Outcomes, Neonatal Deaths, and Child Growth'. Together they form a unique fingerprint.

Cite this